Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 850 of 866 entries
View as:

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)

Phase: N/A Priority: Normal
NCT ID: NCT06977724 Org: User:
Start: 08/14/25 End: 03/31/29 Due: 03/31/30

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06628310 Org: User:
Start: 12/13/24 End: 10/31/30 Due: 10/31/31

Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04472598 Org: User:
Start: 09/29/20 End: 01/29/25 Due: 01/29/26

Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04477486 Org: User:
Start: 09/23/20 End: 06/02/25 Due: 06/02/26

A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT04309474 Org: User:
Start: 11/09/20 End: 12/23/24 Due: 12/23/25

Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT03868163 Org: User:
Start: 02/28/19 End: 09/04/20 Due: 09/04/21

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)

Phase: N/A Priority: Normal
NCT ID: NCT04567550 Org: User:
Start: 11/20/20 End: 09/30/26 Due: 09/30/27

A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Phase: N/A Priority: Normal
NCT ID: NCT06902558 Org: User:
Start: 05/01/25 End: 09/30/29 Due: 09/30/30

A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02955251 Org: User:
Start: 11/18/16 End: 10/29/19 Due: 10/29/20

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03033498 Org: User:
Start: 05/17/17 End: 06/08/19 Due: 06/08/20

A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02141282 Org: User:
Start: 09/10/14 End: 12/22/21 Due: 12/22/22

Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02289690 Org: User:
Start: 10/13/14 End: 04/17/19 Due: 04/17/20

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Phase: N/A Priority: Normal
NCT ID: NCT02581189 Org: User:
Start: 10/13/15 End: 12/20/17 Due: 12/20/18

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02106546 Org: User:
Start: 04/10/14 End: 11/20/19 Due: 11/20/20

A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04178317 Org: User:
Start: 04/02/20 End: 09/30/25 Due: 09/30/26

A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06887010 Org: User:
Start: 03/25/25 End: 05/31/25 Due: 05/31/26

A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications

Phase: N/A Priority: Normal
NCT ID: NCT01960842 Org: User:
Start: 10/31/13 End: 03/31/15 Due: 03/31/16

A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04178902 Org: User:
Start: 05/19/20 End: 04/16/21 Due: 04/16/22

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

Phase: N/A Priority: Normal
NCT ID: NCT03002818 Org: User:
Start: 03/01/17 End: 04/25/18 Due: 04/25/19

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Phase: N/A Priority: Normal
NCT ID: NCT05105841 Org: User:
Start: 11/08/21 End: 10/26/25 Due: 10/26/26

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03001115 Org: User:
Start: 03/10/17 End: 07/31/19 Due: 07/31/20

A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT04189627 Org: User:
Start: 02/17/20 End: 06/24/21 Due: 06/24/22

Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04912063 Org: User:
Start: 06/25/21 End: 05/09/23 Due: 05/09/24

A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05291234 Org: User:
Start: 08/15/22 End: 10/31/25 Due: 10/31/26

A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis

Phase: N/A Priority: Normal
NCT ID: NCT01148225 Org: User:
Start: 11/23/10 End: 05/21/18 Due: 05/21/19